{"id":"W4411739445","doi":"10.1080/14737159.2025.2521538","title":"From barriers to solutions: an expert-based algorithm for cholangiocarcinoma and other biliary tract cancers testing in the Era of precision oncology","year":2025,"lang":"en","type":"review","venue":"Expert Review of Molecular Diagnostics","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital","funders":"Chugai Pharmaceutical; Sirtex Medical; Servier; Boston Scientific Corporation; European Cooperation in Science and Technology; Relay Therapeutics; Seagen; Pfizer; Incyte; Jazz Pharmaceuticals; Ipsen; BeiGene; Les Laboratories Pierre Fabre; FibroGen; Astellas Pharma; Eisai; Sanofi; Exelixis; Mylan; AstraZeneca; Novocure; Amgen; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Biliary tract cancer; Medicine; Precision oncology; Biliary tract; Precision medicine; Internal medicine; Oncology; Algorithm; Cancer; Pathology; Computer science; Gemcitabine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007587322,0.0004692787,0.002559653,0.0002111254,0.00007482221,0.00001194844,0.0003700755,0.0002496283,0.00001781903],"category_scores_gemma":[0.005729637,0.0003220177,0.0005447593,0.0006255601,0.0001372734,0.00003409864,0.0001014956,0.0003665763,6.178023e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002954575,"about_ca_system_score_gemma":0.001869365,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001284057,"about_ca_topic_score_gemma":0.0000537499,"domain_scores_codex":[0.9971153,0.0004841114,0.001104052,0.0006054945,0.0003562314,0.0003347992],"domain_scores_gemma":[0.9942168,0.004146277,0.0004162111,0.0007824592,0.0002423388,0.0001959026],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001390147,0.0001494953,0.00008241644,0.01918806,0.0001456063,0.00005185026,0.0007316148,8.108914e-7,0.000008502717,0.000005756437,0.004798105,0.9748239],"study_design_scores_gemma":[0.0008433222,0.0009378534,0.0001309976,0.239491,0.001407551,0.00002267861,0.0003601449,0.00008405242,0.0000490336,0.00001418259,0.7563299,0.0003293434],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002929099,0.9916857,0.002441784,0.0007297288,0.0002329701,0.004312786,0.0004684866,0.00001397256,0.00008520646],"genre_scores_gemma":[0.00002770817,0.9589031,0.03141319,0.007273035,0.0002215071,0.001934196,0.0001727703,0.00005236205,0.000002101824],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9744945,"threshold_uncertainty_score":0.9999232,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05559624531280107,"score_gpt":0.3928302502004648,"score_spread":0.3372340048876638,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}